Page 2 - Advm News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Adverum Biotechnologies (NASDAQ:ADVM – Get Free Report) and Agenus (NASDAQ:AGEN – Get Free Report) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their analyst recommendations, earnings, institutional ownership, risk, valuation, dividends and profitability. Risk and Volatility Adverum Biotechnologies has a beta […]

ADVM | Complete Adverum Biotechnologies Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.

Marquette Asset Management LLC decreased its stake in shares of Adverum Biotechnologies, Inc. (NASDAQ:ADVM – Free Report) by 50.5% in the 3rd quarter, according to its most recent 13F filing with the SEC. The firm owned 60,120 shares of the biotechnology company’s stock after selling 61,273 shares during the period. Marquette Asset Management LLC owned […]

Commodore Capital LP grew its holdings in shares of Adverum Biotechnologies, Inc. (NASDAQ:ADVM – Free Report) by 100.0% in the 2nd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 10,000,000 shares of the biotechnology company’s stock after purchasing an additional 5,000,000 shares during the quarter. Adverum […]

BML Capital Management LLC reduced its stake in shares of Adverum Biotechnologies, Inc. (NASDAQ:ADVM – Free Report) by 27.0% during the 2nd quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 5,157,179 shares of the biotechnology company’s stock after selling 1,910,000 shares during the period. Adverum Biotechnologies makes up […]